AA amyloidosis as a complication of primary lymphedema. 2014

François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
LUNAM University, Angers , France .

Primary lymphedema is a rare disease caused by a disorder of lymphangiogenesis. Clinical presentation and age at onset are variable. AA amyloidosis is usually due to chronic inflammatory diseases, malignant tumors or less frequently chronic infectious diseases. We report here the first two cases of AA amyloidosis present with renal failure and nephrotic syndrome in patients with primary lymphedema-induced chronic leg ulcers. The first patient was a 62-year-old female who presented with chronic untreated leg ulcers for 8 years secondary to primary lymphedema. A kidney biopsy done for nephrotic syndrome allowed the diagnosis of AA amyloidosis. The second patient was a 54-year-old male who presented with hereditary lymphedema and elephantiasis since the age of 12. A salivary gland biopsy allowed the diagnosis of AA amyloidosis. Renal function deteriorated progressively needing chronic haemodialysis. Chronic leg ulcers have been rarely reported to induce AA amyloidosis. Only five other cases have been reported in the literature, but none of them with chronic lymphedema. We believe that the relation between lymphedema, chronic leg ulcers and AA amyloidosis is underestimated.

UI MeSH Term Description Entries
D008209 Lymphedema Edema due to obstruction of lymph vessels or disorders of the lymph nodes. Milroy's Disease,Congenital Familial Lymphedema,Congenital Hereditary Lymphedema,Early Onset Lymphedema,Hereditary Lymphedema,Hereditary Lymphedema 1,Hereditary Lymphedema Type I,Lymphedema, Early-Onset,Lymphedema, Hereditary, Ia,Milroy Disease,Nonne-Milroy Disease,Nonne-Milroy Lymphedema,Nonne-Milroy-Meige Disease,Primary Congenital Lymphedema,Congenital Hereditary Lymphedemas,Congenital Lymphedema, Primary,Congenital Lymphedemas, Primary,Early Onset Lymphedemas,Early-Onset Lymphedema,Early-Onset Lymphedemas,Hereditary Lymphedema 1s,Hereditary Lymphedema, Congenital,Hereditary Lymphedemas,Hereditary Lymphedemas, Congenital,Lymphedema, Congenital Hereditary,Lymphedema, Early Onset,Lymphedema, Hereditary,Lymphedema, Nonne-Milroy,Lymphedema, Primary Congenital,Lymphedemas,Lymphedemas, Congenital Hereditary,Lymphedemas, Early Onset,Lymphedemas, Early-Onset,Lymphedemas, Hereditary,Lymphedemas, Primary Congenital,Milroys Disease,Nonne Milroy Disease,Nonne Milroy Lymphedema,Nonne Milroy Meige Disease,Primary Congenital Lymphedemas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000685 Serum Amyloid A Protein An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS. Amyloid Protein SAA,Amyloid Serum Protein SAA,Serum A Related Protein,Amyloid A Precursor,Amyloid A Protein,Amyloid A Protein-Related Serum Component,Amyloid Fibril Protein AA,Amyloid Protein AA,Amyloid Protein AA Precursor,Amyloid-Related Serum Protein (SAA),Serum Amyloid A,Serum Amyloid Protein A,Amyloid A Protein Related Serum Component
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D012883 Skin Ulcer An ULCER of the skin and underlying tissues. Skin Ulcers,Ulcer, Skin,Ulcers, Skin
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
January 1999, Srpski arhiv za celokupno lekarstvo,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
February 2008, Annales de dermatologie et de venereologie,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
January 2008, The British journal of dermatology,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
July 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
July 1983, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
May 1991, Nihon Jinzo Gakkai shi,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
January 2020, Indian journal of nephrology,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
October 2017, Annals of rehabilitation medicine,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
September 2007, Neurology,
François Beloncle, and Johnny Sayegh, and Caroline Eymerit-Morin, and Agnès Duveau, and Jean-François Augusto
July 2008, Nephrologie & therapeutique,
Copied contents to your clipboard!